News
Non-Vitamin K Antagonist Oral Anticoagulants vs Warfarin in NVAF Patients
Findings may help with decision-making in this high-risk patient population.
Your search for dabigatran returned 43 results
News
Pradaxa Approved to Treat, Prevent VTE in Pediatric Patients
Pradaxa oral pellets are supplied in child-resistant packets in 20mg, 30mg, 40mg, 50mg, 110mg, and 150mg dosage strengths.
News
Severe Abnormal Uterine Bleeding Risk With Anticoagulant Therapy Examined
Study findings revealed an increased risk of surgical intervention in women exposed to rivaroxaban.
News
Study Reveals Previously Unknown Drug-Associated Arrhythmias
To identify medications with potential proarrhythmic association.
News
Bleeding Risk Assessed With Concomitant Direct Oral Anticoagulants and Verapamil or Diltiazem
Concomitant use of dabigatran with verapamil or diltiazem was found to be associated with an increased risk of bleeding in patients with normal kidney function, according to the findings of a recently published retrospective cohort study.
News, Urological Disorders
Study IDs Meds Commonly Used in Primary Care That Should Be Dose Adjusted, Avoided in CKD
A list of medications routinely prescribed in primary care practice that should be used cautiously or avoided in patients with chronic kidney disease (CKD) was compiled in a recently published study in the Annals of Pharmacotherapy.
Features, News
Consider CBD-Drug Interaction Potential: An Expert Interview
To shed light on this complex subject, MPR interviewed Joshua D Brown, PharmD, PhD, Assistant Professor, Pharmaceutical Outcomes & Policy.
News
WHO Updates List of Essential Medicines
The World Health Organization (WHO) has updated the WHO Model List of Essential Medicines for 2019.
News
Dabigatran Safe, Effective for Managing VTE in Pediatric Trials
The open label, randomized, multicenter, phase 2b/3 DIVERSITY trial evaluated the efficacy and safety of dabigatran compared with SOC (low molecular weight heparin or vitamin K antagonist) in 240 children.
News
Attorney Ads May Influence DOAC Users to Discontinue Meds Without Medical Advice
According to the findings of a recent study, attorney advertisements appear to influence patients’ decisions on modifying or discontinuing their direct oral anticoagulant (DOAC) medication prior to seeking medical advice.
